[Use of immunochemical studies to predict the course of fibrous cavernous tuberculosis of lung and postoperative complications in patients on chemo and laser therapy].
A total of 103 patients with fibrocavernous tuberculosis of the lung were examined. They all received chemotherapy, including 3 - 4 antituberculous agents. Laser therapy was performed with a UZOR-2K low-energy semiconductor laser. In patients with profound changes in the serum level of protein, with high antigenemia and antibody production, the course of the disease was found to be poor; X-ray positive changes were achieved to a lesser extent, bacterial expellation stopped less frequently and more slowly. The decreases in the serum content of the proteins tested, in the level of antigenemia and antibody production which occur with drug and laser therapies are also an important factor of preoperative preparation, which is highly effective in preventing postoperative complications.
Sergeeva
L V
LV
Central NII of Tuberculosis RAMN, Moscow.
Dobkin
V G
VG
Baenskií
A V
AV
Kulikovskaia
N V
NV
Litvinov
V I
VI
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007120:Immunochemistry / Q000379:methods*; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology; D011183:Postoperative Complications / Q000517:prevention & control*; D011237:Predictive Value of Tests; D014373:Tuberculin / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*
D000907:Antibodies, Bacterial; D000995:Antitubercular Agents; D014373:Tuberculin